TY - JOUR
T1 - Neonatal Life Support 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations
AU - Wyckoff, Myra H.
AU - Wyllie, Jonathan
AU - Aziz, Khalid
AU - de Almeida, Maria Fernanda
AU - Fabres, Jorge W.
AU - Fawke, Joe
AU - Guinsburg, Ruth
AU - Hosono, Shigeharu
AU - Isayama, Tetsuya
AU - Kapadia, Vishal S.
AU - Kim, Han Suk
AU - Liley, Helen G.
AU - McKinlay, Christopher J.D.
AU - Mildenhall, Lindsay
AU - Perlman, Jeffrey M.
AU - Rabi, Yacov
AU - Roehr, Charles C.
AU - Schmölzer, Georg M.
AU - Szyld, Edgardo
AU - Trevisanuto, Daniele
AU - Velaphi, Sithembiso
AU - Weiner, Gary M.
AU - Davis, Peter G.
AU - Dawson, Jennifer
AU - Ersdal, Hege
AU - Foglia, Elizabeth E.
AU - Kawakami, Mandira
AU - Lee, Henry C.
AU - Rüdiger, Mario
AU - Sawyer, Taylor
AU - Soraisham, Amouchou
AU - Strand, Marya
AU - Udaeta, Enrique
AU - Urlesburger, Berndt
AU - Yamada, Nicole K.
AU - Madar, John
AU - Escobedo, Marilyn B.
AU - Ganguly, Abhrajit
AU - Gately, Callum
AU - Kamath-Rayne, Beena
AU - Mausling, Richard
AU - Domingo-Bates, Jocelyn
AU - Nakwa, Firdose
AU - Ramachandran, Shalini
AU - Ring, Jenny
AU - Shah, Birju
AU - Stave, Christopher
AU - Tamura, Masanori
AU - Pas, Arjan te
N1 - Publisher Copyright:
© 2020
PY - 2020/11
Y1 - 2020/11
N2 - This 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations (CoSTR) for neonatal life support includes evidence from 7 systematic reviews, 3 scoping reviews, and 12 evidence updates. The Neonatal Life Support Task Force generally determined by consensus the type of evidence evaluation to perform; the topics for the evidence updates followed consultation with International Liaison Committee on Resuscitation member resuscitation councils. The 2020 CoSTRs for neonatal life support are published either as new statements or, if appropriate, reiterations of existing statements when the task force found they remained valid. Evidence review topics of particular interest include the use of suction in the presence of both clear and meconium-stained amniotic fluid, sustained inflations for initiation of positive-pressure ventilation, initial oxygen concentrations for initiation of resuscitation in both preterm and term infants, use of epinephrine (adrenaline) when ventilation and compressions fail to stabilize the newborn infant, appropriate routes of drug delivery during resuscitation, and consideration of when it is appropriate to redirect resuscitation efforts after significant efforts have failed. All sections of the Neonatal Resuscitation Algorithm are addressed, from preparation through to postresuscitation care. This document now forms the basis for ongoing evidence evaluation and reevaluation, which will be triggered as further evidence is published. Over 140 million babies are born annually worldwide (https://ourworldindata.org/grapher/births-and-deaths-projected-to-2100). If up to 5% receive positive-pressure ventilation, this evidence evaluation is relevant to more than 7 million newborn infants every year. However, in terms of early care of the newborn infant, some of the topics addressed are relevant to every single baby born.
AB - This 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations (CoSTR) for neonatal life support includes evidence from 7 systematic reviews, 3 scoping reviews, and 12 evidence updates. The Neonatal Life Support Task Force generally determined by consensus the type of evidence evaluation to perform; the topics for the evidence updates followed consultation with International Liaison Committee on Resuscitation member resuscitation councils. The 2020 CoSTRs for neonatal life support are published either as new statements or, if appropriate, reiterations of existing statements when the task force found they remained valid. Evidence review topics of particular interest include the use of suction in the presence of both clear and meconium-stained amniotic fluid, sustained inflations for initiation of positive-pressure ventilation, initial oxygen concentrations for initiation of resuscitation in both preterm and term infants, use of epinephrine (adrenaline) when ventilation and compressions fail to stabilize the newborn infant, appropriate routes of drug delivery during resuscitation, and consideration of when it is appropriate to redirect resuscitation efforts after significant efforts have failed. All sections of the Neonatal Resuscitation Algorithm are addressed, from preparation through to postresuscitation care. This document now forms the basis for ongoing evidence evaluation and reevaluation, which will be triggered as further evidence is published. Over 140 million babies are born annually worldwide (https://ourworldindata.org/grapher/births-and-deaths-projected-to-2100). If up to 5% receive positive-pressure ventilation, this evidence evaluation is relevant to more than 7 million newborn infants every year. However, in terms of early care of the newborn infant, some of the topics addressed are relevant to every single baby born.
KW - AHA Scientific Statements
KW - cardiopulmonary resuscitation
KW - neonatal resuscitation
KW - neonate
UR - http://www.scopus.com/inward/record.url?scp=85093678437&partnerID=8YFLogxK
U2 - 10.1016/j.resuscitation.2020.09.015
DO - 10.1016/j.resuscitation.2020.09.015
M3 - Artículo
C2 - 33084392
AN - SCOPUS:85093678437
SN - 0300-9572
VL - 156
SP - A156-A187
JO - Resuscitation
JF - Resuscitation
ER -